Can indomethacin or colchicine cause gross hematuria?

Can Indomethacin or Colchicine Cause Gross Hematuria?

Neither indomethacin nor colchicine are recognized as direct causes of gross hematuria in clinical practice, though both drugs should be avoided in patients with severe renal impairment where hematuria may occur from underlying kidney disease.

Indomethacin and Hematuria

Indomethacin, like other NSAIDs, does not directly cause gross hematuria. However, it can increase bleeding risk through several mechanisms:

• Platelet dysfunction: NSAIDs inhibit platelet aggregation and prolong bleeding time, though this effect is quantitatively less than aspirin and reversible 1
• Gastrointestinal bleeding: The primary bleeding concern with indomethacin is GI tract ulceration and bleeding, not urinary tract bleeding 2
• Renal effects: The FDA label notes hematological effects including anemia, but this relates to GI blood loss or effects on erythropoiesis, not gross hematuria 1

Key clinical point: If a patient on indomethacin develops gross hematuria, the drug is not the likely culprit—pursue full urologic workup as gross hematuria has a 30-40% association with malignancy 3.

Colchicine and Hematuria

Colchicine is not a recognized cause of gross hematuria. The evidence shows:

• Toxicity profile: Colchicine overdose causes GI symptoms, multiorgan failure, bone marrow suppression, and renal insufficiency—but not hematuria as a primary manifestation 4
• Renal considerations: Both EULAR and ACP guidelines emphasize avoiding colchicine in severe renal impairment (GFR <30 mL/min) due to reduced clearance and toxicity risk, not because it causes hematuria 5
• Paradoxical use: Colchicine has actually been used to treat conditions causing gross hematuria, such as bladder amyloidosis 6

Important Caveats

When These Drugs Appear Related to Hematuria

1. Familial Mediterranean Fever (FMF): Patients with FMF can present with gross hematuria as part of their disease manifestations, and colchicine is the treatment, not the cause 7, 8

2. Renal impairment: Both drugs require dose adjustment or avoidance in severe renal disease 5, 9. If hematuria occurs in this setting, it reflects the underlying kidney pathology, not drug effect.

3. Drug interactions: Colchicine with P-glycoprotein/CYP3A4 inhibitors (clarithromycin, cyclosporin, ketoconazole) increases toxicity risk, but the toxicity manifests as neuromuscular symptoms, GI distress, and multiorgan failure—not hematuria 4, 5

Contrast with True Hematuria-Causing Drugs

Large pharmacovigilance studies identify the actual culprits for drug-induced hematuria 10, 11, 12:

• Anticoagulants (warfarin, rivaroxaban, dabigatran, apixaban)
• Antiplatelet agents (aspirin, clopidogrel)
• Cyclophosphamide

Neither indomethacin nor colchicine appear in these analyses as significant causes of hematuria.

Clinical Algorithm for Gross Hematuria in Patients on These Drugs

Do not attribute gross hematuria to indomethacin or colchicine. Instead:

1. Immediately pursue full urologic evaluation including cystoscopy and CT urography, as gross hematuria carries 30-40% malignancy risk 3

2. Check for true bleeding risk factors:

   • Concurrent anticoagulants/antiplatelets
   • Renal impairment (measure creatinine, eGFR)
   • Drug interactions increasing colchicine levels

3. Consider underlying conditions:

   • For colchicine patients: Is this FMF with renal involvement?
   • For indomethacin patients: Gout with concurrent urolithiasis?

4. Do not delay workup based on medication use—anticoagulation does not alter the need for hematuria evaluation 3, 13